Cargando…

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

BACKGROUND: The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects the gut microbiota in humans with non-haematological malignancy, independent o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papanicolas, Lito E., Sims, Sarah K., Taylor, Steven L., Miller, Sophie J., Karapetis, Christos S., Wesselingh, Steve L., Gordon, David L., Rogers, Geraint B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141218/ https://www.ncbi.nlm.nih.gov/pubmed/34022842 http://dx.doi.org/10.1186/s12885-021-08296-4

Ejemplares similares

Do we really understand how faecal microbiota transplantation works? Authors' reply
por: Papanicolas, Lito E., et al.
Publicado: (2019)

Bacterial viability in faecal transplants: Which bacteria survive?
por: Papanicolas, Lito E., et al.
Publicado: (2019)

DNA extraction approaches substantially influence the assessment of the human breast milk microbiome
por: Douglas, Chloe A., et al.
Publicado: (2020)

Ear microbiota and middle ear disease: a longitudinal pilot study of Aboriginal children in a remote south Australian setting
por: Taylor, Steven L., et al.
Publicado: (2022)

Examining the Evidence for an Adult Healthy Middle Ear Microbiome
por: Jervis-Bardy, Jake, et al.
Publicado: (2019)

Draft Genome Sequences of Two Enterobacter cloacae subsp. cloacae Strains Isolated from Australian Hematology Patients with Bacteremia
por: Leong, Lex E. X., et al.
Publicado: (2017)

Cohort profile: GRACE – a residential aged care cohort examining factors influencing antimicrobial resistance carriage
por: Carpenter, Lucy, et al.
Publicado: (2023)

TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy
por: Brenet, Fabienne, et al.
Publicado: (2013)

Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer
por: Zheng, Ziming, et al.
Publicado: (2022)

Infection’s Sweet Tooth: How Glycans Mediate Infection and Disease Susceptibility
por: Taylor, Steven L., et al.
Publicado: (2018)

Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis
por: Choo, Jocelyn M., et al.
Publicado: (2018)

Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
por: Gawade, Prasad L., et al.
Publicado: (2020)

Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
por: Epstein, Robert S, et al.
Publicado: (2021)

Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
por: Otsuka, Yuki, et al.
Publicado: (2020)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
por: Brugnatelli, S., et al.
Publicado: (1996)

A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol
por: Vatandoust, Sina, et al.
Publicado: (2022)

An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy
por: Baggott, Christina R., et al.
Publicado: (2010)

Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy
por: Matsui, Kaoru, et al.
Publicado: (1996)

Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression
por: Brenet, Fabienne, et al.
Publicado: (2015)

The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
por: Zecha, Judith A. E. M., et al.
Publicado: (2019)

Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review
por: Pan, Linlin, et al.
Publicado: (2020)

The gut microbiome regulates host glucose homeostasis via peripheral serotonin
por: Martin, Alyce M., et al.
Publicado: (2019)

Myelosuppression by sunitinib is flt-3 genotype dependent
por: van Erp, N P, et al.
Publicado: (2010)

TIRAP drives myelosuppression through an Ifnγ–Hmgb1 axis that disrupts the endothelial niche in mice
por: Gopal, Aparna, et al.
Publicado: (2022)

Intestinal microbiology shapes population health impacts of diet and lifestyle risk exposures in Torres Strait Islander communities
por: Mobegi, Fredrick M, et al.
Publicado: (2020)

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.
por: Dercksen, M. W., et al.
Publicado: (1993)

Infusion of allogeneic umbilical cord blood hematopoietic stem cells in patients with chemotherapy-related myelosuppression
por: YAO, YI, et al.
Publicado: (2014)

Effects of Traditional Chinese Medicine on Chemotherapy-Induced Myelosuppression and Febrile Neutropenia in Breast Cancer Patients
por: Tian, Huan, et al.
Publicado: (2015)

The nasopharyngeal microbiome and LRTIs in infants
por: Rogers, Geraint B
Publicado: (2019)

The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study
por: Ji, Yajie, et al.
Publicado: (2021)

Translational Modeling of Drug‐Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor
por: Collins, TA, et al.
Publicado: (2017)

Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors
por: Epstein, Robert S., et al.
Publicado: (2020)

ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression
por: Drenberg, CD, et al.
Publicado: (2016)

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
por: Kumar, R, et al.
Publicado: (2009)

Sleeping through the storm: Preventing myelosuppression with quizartinib
por: Taylor, Samuel J., et al.
Publicado: (2017)

Antineoplastics: Myelosuppression and COVID-19: case report
Publicado: (2020)

Palbociclib: Myelosuppression and gastrointestinal reactions: case report
Publicado: (2022)

Chinese Herbal Medicine for Myelosuppression Induced by Chemotherapy or Radiotherapy: A Systematic Review of Randomized Controlled Trials
por: Jia, Youji, et al.
Publicado: (2015)

The efficacy of dietary Spirulina as an adjunct to chemotherapy to improve immune function and reduce myelosuppression in patients with malignant tumors
por: Ge, Yang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_57efg1mqd466equo7c3s9h0j9f